Mitsubishi Chemical Group Corporation
Notice Regarding Revision of Investment Plan for Ethylene Vinyl Alcohol Copolymer Resin “Soarnol™” in the UK
Due to the revision of the Soarnol™ UK plant investment plan, an impairment loss of approximately 30 billion yen is scheduled to be recorded in the fiscal year ending March 2026. The investment amount has increased and construction delays have occurred, resulting in expected decreased profitability.
Key Figures
- Impairment Loss: Approximately 30 billion yen (Scheduled to be recorded in FY March 2026)
- Revenue Forecast: 3,672,000 million yen (FY March 2026)
- Core Operating Income Forecast: 250,000 million yen (FY March 2026)
AI要約
Overview of Investment Plan Revision
Mitsubishi Chemical UK Limited, a consolidated subsidiary of Mitsubishi Chemical Group, manufactures and sells the ethylene vinyl alcohol copolymer resin "Soarnol™." Due to increased complexity in design and construction as well as global inflation driving higher material and labor costs, construction expenses have exceeded initial estimates, and delays in the construction schedule have occurred, leading to a decision to increase the investment amount. The new production facilities are scheduled to start operation in fiscal year 2027.
Impact on Performance and Future Response
Profitability is expected to decline due to the increased investment amount, and an impairment loss of approximately 30 billion yen is scheduled to be recorded in the fiscal year ending March 2026. This impairment loss was not reflected in the earnings guidance announced on February 5, 2026, and the necessity for revising future earnings guidance is currently under review. The "Soarnol™" product remains positioned as a growth driver for the company and retains its importance as a material supporting food quality preservation.
Mitsubishi Chemical Group Corporation
Company overview · Stock price · Financial data · All IR
